TopoTarget

From WikiMD.com Medical Encyclopedia

TopoTarget[edit | edit source]

Logo of TopoTarget

TopoTarget was a biotechnology company focused on the development of cancer therapies. Founded in 2000, the company was based in Copenhagen, Denmark. TopoTarget specialized in the research and development of histone deacetylase inhibitors (HDAC inhibitors) and other targeted therapies for the treatment of cancer.

History[edit | edit source]

TopoTarget was established by a group of scientists and entrepreneurs with expertise in cancer research and drug development. The company aimed to develop innovative treatments that target specific mechanisms involved in cancer progression. In 2004, TopoTarget was listed on the Copenhagen Stock Exchange.

Research and Development[edit | edit source]

TopoTarget's research primarily focused on HDAC inhibitors, which are compounds that interfere with the function of histone deacetylases. These enzymes play a crucial role in the regulation of gene expression by modifying the chromatin structure. By inhibiting HDACs, TopoTarget aimed to reactivate tumor suppressor genes and induce apoptosis in cancer cells.

Hsp90, a protein targeted by some of TopoTarget's research

One of the company's lead compounds was belinostat, an HDAC inhibitor that showed promise in the treatment of various cancers, including peripheral T-cell lymphoma. Belinostat was developed in collaboration with other pharmaceutical companies and underwent several clinical trials.

Acquisition[edit | edit source]

In 2014, TopoTarget merged with BioAlliance Pharma, a French biotechnology company, to form Onxeo. This merger was aimed at creating a stronger entity with a broader portfolio of oncology products and a more extensive pipeline of drug candidates.

Related pages[edit | edit source]

References[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD